Cargando…
Histone Deacetylases (HDACs) and Atherosclerosis: A Mechanistic and Pharmacological Review
Atherosclerosis (AS), the most common underlying pathology for coronary artery disease, is a chronic inflammatory, proliferative disease in large- and medium-sized arteries. The vascular endothelium is important for maintaining vascular health. Endothelial dysfunction is a critical early event leadi...
Autores principales: | Chen, Xiaona, He, Yanhong, Fu, Wenjun, Sahebkar, Amirhossein, Tan, Yuhui, Xu, Suowen, Li, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688915/ https://www.ncbi.nlm.nih.gov/pubmed/33282862 http://dx.doi.org/10.3389/fcell.2020.581015 |
Ejemplares similares
-
Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
por: Phimmachanh, Monica, et al.
Publicado: (2020) -
The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy
por: Li, Guo, et al.
Publicado: (2020) -
Nanotechnology-Based Histone Deacetylase Inhibitors for Cancer Therapy
por: Tu, Bin, et al.
Publicado: (2020) -
Editorial: Epigenetic Therapy With Histone Deacetylase Inhibitors: Implications for Cancer Treatment
por: Sousa, Angela, et al.
Publicado: (2021) -
Comprehensive Analysis of the Differential Expression and Prognostic Value of Histone Deacetylases in Glioma
por: Li, Jinwei, et al.
Publicado: (2022)